DePuy Synthes unveiled its PROTI 360° Integrated Titanium Family of interbody devices.
The Latest
The Association of American Medical Colleges released a new report on the careers of physician-scientists. The study analyzes the careers of MD-PhD dual-degree program graduates between 1964 and 2014.
The phase I/II U.S. clinical trial testing DiscGenics' IDCT for treating degenerative disc disease is underway.
With the recent expansion of its Tritanium cages line, Stryker plans to showcase the devices at the American Association of Neurological Surgeons annual meeting, April 28 to May 2 in New Orleans.
In the first quarter of 2018, Stryker saw growth in all aspects of its business. The company released its financial results to provide further detail.
Los Gatos, Calif.-based OrthoNorCal opened its newest office in Morgan Hill, Calif.
Similar to other compensation survey data, there has been a consistent upward trend in CEO compensation.
Stryker CEO thinks 50% of hospitals with orthopedic practices are candidates for Mako — 5 key quotes
Stryker reported a 9.2 percent increase in first quarter sales to $3.2 billion, with a 7.1 percent increase in orthopedic sales year-over-year.
Zimmer Biomet CEO Bryan Hanson has been on a mission to improve company culture since taking the reins last year, and continues to focus on the cultural integration of Zimmer and Biomet, which officially merged in 2015.
A Los Angeles County jury found William Dobkin, MD, of Newport Beach, Calif.-based Hoag Hospital, not negligent in a case involving the off-label use of Medtronic's Infuse, according to Courtroom View Network.